Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Imfinzi (durvalumab) Disease area(s): Oncology Manufacturer(s): AstraZeneca 2024 Sales (USD): $4.72 billion Why it sold so well: In 2024, AstraZenecas Imfinzi experienced strong sales growth, driven by expanded indications and robust clinical trial results
The honest answer: relaxed, comfortable and uneventful which is exactly what a good wellness infusion should feel like
To ensure maximum potency, Store unmixed vials in a cool and dry place
B.FleisherA
US$ 26.22
US$ 20.32
US$ 23.03
